Cubist Systematic Strategies’s CureVac CVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-51,174
Closed -$142K 3074
2025
Q1
$142K Buy
+51,174
New +$178K ﹤0.01% 2580
2024
Q2
Sell
-11,387
Closed -$34.5K 3181
2024
Q1
$34.5K Buy
11,387
+754
+7% +$2.65K ﹤0.01% 3425
2023
Q4
$44.8K Buy
+10,633
New +$57.7K ﹤0.01% 3281
2023
Q3
Sell
-12,377
Closed -$129K 3447
2023
Q2
$129K Buy
12,377
+3,898
+46% +$34.9K ﹤0.01% 2941
2023
Q1
$59.1K Buy
+8,479
New +$73.9K ﹤0.01% 3539
2022
Q4
Sell
-11,915
Closed -$94K 4303
2022
Q3
$94K Sell
11,915
-146,605
-92% -$1.71M ﹤0.01% 4032
2022
Q2
$2.16M Buy
158,520
+96,801
+157% +$1.6M 0.01% 1786
2022
Q1
$1.21M Buy
61,719
+55,818
+946% +$1.11M 0.01% 1893
2021
Q4
$202K Sell
5,901
-7,305
-55% -$294K ﹤0.01% 3024
2021
Q3
$721K Sell
13,206
-17,300
-57% -$1.04M 0.01% 1774
2021
Q2
$2.24M Buy
+30,506
New +$3.05M 0.03% 1011
2021
Q1
Sell
-12,700
Closed -$1.03M 2853
2020
Q4
$1.03M Buy
+12,700
New +$972K 0.01% 1367

Other funds holding CVAC

Cubist Systematic Strategies's CVAC Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of CureVac (CVAC) in Q2 2025, closing a stake of 51,174 shares — an estimated $142K sold.

Cubist Systematic Strategies first reported a position in CVAC in Q4 2020 and held it in 12 quarters. The position peaked at $2.24M in Q2 2021. 91 funds tracked by Wall St. Rank hold CVAC as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining CureVac position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 51,174 CureVac shares in Q2 2025, an estimated $142K.
  • Cubist Systematic Strategies first reported a position in CureVac in Q4 2020 and held it in 12 quarters.
  • Cubist Systematic Strategies's CureVac position peaked at $2.24M in Q2 2021.
  • 91 funds tracked by Wall St. Rank held CureVac as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.